May 7, 2020 / 12:53 PM / a month ago

BRIEF-Lineage Cell Therapeutics Announces Early Exercise Of Option With Cancer Research UK For Immuno-Oncology Cell Therapy Program

May 7 (Reuters) - Lineage Cell Therapeutics Inc:

* LINEAGE CELL THERAPEUTICS ANNOUNCES EARLY EXERCISE OF OPTION WITH CANCER RESEARCH UK FOR IMMUNO-ONCOLOGY CELL THERAPY PROGRAM

* LINEAGE CELL THERAPEUTICS INC - LINEAGE WILL ASSUME RESPONSIBILITY FOR FURTHER DEVELOPMENT OF VAC2 PRODUCT CANDIDATE

* LINEAGE CELL THERAPEUTICS INC - LINEAGE WILL ASSUME RESPONSIBILITY FOR FUTURE DEVELOPMENT OPPORTUNITIES DERIVED FROM VAC PLATFORM

* LINEAGE CELL THERAPEUTICS INC - CANCER RESEARCH UK WILL PROVIDE INPUT ON POTENTIAL USE OF VAC IN INFECTIOUS DISEASE SPACE TO DEVELOP A VACCINE AGAINST SARS-COV-2 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below